CancerDrs

Lymphoma

Hodgkin and non-Hodgkin lymphoma subtypes. Trials explore CAR-T therapy, bispecific antibodies, and relapsed/refractory regimens.

74.2%
5-year relative survival
U.S. average across all stages
300
recruiting trials
Active in the U.S. right now
80,350
new diagnoses / year
You are not alone — roughly 220 people per day
68
median age at diagnosis
Most diagnoses occur in adults over age 50

Source: NCI SEER + ClinicalTrials.gov

Lymphoma by the numbers (U.S.)

80,350
Estimated new cases (2025)
19,390
Estimated deaths (2025)
74.2%
5-year relative survival
68
Median age at diagnosis

Source: NCI SEER Cancer Stat Facts

Lymphoma clinical trials →

300 actively recruiting trials across the U.S., with filters by state.

Second opinion for lymphoma →

Step-by-step for getting a virtual second opinion from a top cancer center.

NCI-designated cancer centers →

All 71 NCI cancer centers with hospital quality data and state browser.

Find a medical oncologist →

Licensed oncologists across every U.S. state, by specialty.

Financial aid resources →

Co-pay relief, drug patient-assistance, transportation, and lodging support.

Patient guides →

How to read a pathology report, questions to ask your oncologist, staging explained.

Also known as

Hodgkin lymphoma, non-Hodgkin lymphoma, NHL, DLBCL, follicular lymphoma.

For deeper statistics

See the NCI SEER Cancer Stat Facts page: Lymphoma on SEER →